SGLT2 inhibition and adipose tissue metabolism: current outlook and perspectives | Cardiovascular Diabetology
Zinman B, et al. Cardiovascular outcomes, and mortality in type 2 diabetes. N Engl J Med. 2015;373:2117–28. Empagliflozin.Article CAS PubMed ...
